FY2026 · ended Jun 30, 2026 · Revenue $77.55M, +16.5% YoY · Filed Sep 3, 2026
Pro-Dex, Inc. (PDEX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $77.5 million and net income of $13.7 million. Free cash flow was $6.8 million. As of Sep 30, 2026 it held $13.1 million in cash and investments and $2.5 million in total debt.
Revenue (TTM)
$79.58M
+13.3% vs year-ago TTM
Net income (TTM)
$12.03M
+7.5% vs year-ago TTM
Operating cash flow (TTM)
$11.42M
+1007.2% vs year-ago TTM
Free cash flow (TTM)
$10.69M
EPS (TTM)
$3.63
+9.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
3.20M
-1.8% vs prior year
Net cash
$10.59M
as of Sep 30, 2026
Operating margin
16.8%
FY 2027
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PDEX (Nasdaq)
- Fiscal year ends
- June 30
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 788920
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $77.5M | $66.6M | $53.8M | $46.1M | $42.0M |
| Operating income | $13.0M | $10.7M | $7.2M | $5.8M | $5.1M |
| Net income | $13.7M | $9.0M | $2.1M | $7.1M | $4.6M |
| Diluted EPS | $4.12 | $2.67 | $0.60 | $1.95 | $1.21 |
| Operating cash flow | $7.2M | -$1.7M | $6.2M | $5.5M | -$847,000 |
| Free cash flow | $6.8M | — | — | — | -$2.5M |
| Total assets | $74.5M | $61.2M | $52.5M | $51.8M | $49.1M |
| Total liabilities | $26.9M | $24.6M | $21.6M | $20.2M | $23.7M |
| Stockholders' equity | $47.6M | $36.6M | $30.9M | $31.6M | $25.4M |
| Cash and investments | $9.5M | $7.3M | $8.4M | $5.4M | $5.7M |
| Total debt | $18.1M | $16.1M | $13.1M | $14.4M | $16.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Oct 30, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| ARS | Annual report to shareholders | Oct 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 18, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 3, 2026 | Sep 3, 2026 |
All 1000 Pro-Dex, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.